JP2008531701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531701A5 JP2008531701A5 JP2007558123A JP2007558123A JP2008531701A5 JP 2008531701 A5 JP2008531701 A5 JP 2008531701A5 JP 2007558123 A JP2007558123 A JP 2007558123A JP 2007558123 A JP2007558123 A JP 2007558123A JP 2008531701 A5 JP2008531701 A5 JP 2008531701A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- amino
- pharmaceutically acceptable
- combination
- sugar moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 8
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 2
- 230000010933 acylation Effects 0.000 claims 2
- 238000005917 acylation reaction Methods 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- KPPVNWGJXFMGAM-UUILKARUSA-N (e)-2-methyl-1-(6-methyl-3,4-dihydro-2h-quinolin-1-yl)but-2-en-1-one Chemical compound CC1=CC=C2N(C(=O)C(/C)=C/C)CCCC2=C1 KPPVNWGJXFMGAM-UUILKARUSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- NUAQIRUAZSJTAI-YRPZDAAMSA-N O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@H](N)CC(C)C)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@H](N)CC(C)C)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 NUAQIRUAZSJTAI-YRPZDAAMSA-N 0.000 claims 1
- 108010059993 Vancomycin Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229960003165 vancomycin Drugs 0.000 claims 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65763605P | 2005-02-28 | 2005-02-28 | |
| PCT/US2006/007021 WO2006093933A2 (en) | 2005-02-28 | 2006-02-27 | Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009035654A Division JP2009102445A (ja) | 2005-02-28 | 2009-02-18 | 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531701A JP2008531701A (ja) | 2008-08-14 |
| JP2008531701A5 true JP2008531701A5 (enExample) | 2009-04-09 |
Family
ID=36941722
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007558123A Pending JP2008531701A (ja) | 2005-02-28 | 2006-02-27 | 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド |
| JP2009035654A Pending JP2009102445A (ja) | 2005-02-28 | 2009-02-18 | 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009035654A Pending JP2009102445A (ja) | 2005-02-28 | 2009-02-18 | 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7368422B2 (enExample) |
| EP (1) | EP1858908A4 (enExample) |
| JP (2) | JP2008531701A (enExample) |
| AU (1) | AU2006218743A1 (enExample) |
| BR (1) | BRPI0607701A2 (enExample) |
| CA (1) | CA2599336A1 (enExample) |
| WO (1) | WO2006093933A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1818340A4 (en) | 2004-11-29 | 2009-02-25 | Univ Nagoya Nat Univ Corp | ANTIBIOTIC MONOMERS GLYCOPEPTIDE DERIVATIVES |
| US7368422B2 (en) * | 2005-02-28 | 2008-05-06 | Novartis Vaccines And Diagnostics Inc. | Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| US20070185015A1 (en) * | 2005-02-28 | 2007-08-09 | Chiron Corporation and North China Pharmaceutical Corporation | Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| US7632918B2 (en) * | 2005-02-28 | 2009-12-15 | Novartis Vaccines And Diagnostics, Inc. | Semi-synthetic glycopeptides with antibiotic activity |
| TW200808818A (en) | 2006-05-26 | 2008-02-16 | Shionogi & Co | Glycopeptide antibiotic derivatives |
| GB2449156B8 (en) * | 2007-05-08 | 2010-06-02 | Lead Therapeutics Inc | Semi-synthetic glycopeptides with antibacterial activity. |
| KR20100109936A (ko) * | 2007-12-26 | 2010-10-11 | 리드 테라퓨틱스, 인크. | 항박테리아제로서의 신규한 반(半)-합성 글리코펩티드 |
| WO2010048340A2 (en) * | 2008-10-24 | 2010-04-29 | Lead Therapeutics, Inc. | Novel semi-synthetic glycopeptides as antibacterial agents |
| GB2465863A (en) * | 2008-12-05 | 2010-06-09 | Lead Therapeutics Inc | Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections |
| WO2011060222A2 (en) * | 2009-11-13 | 2011-05-19 | Beckman Coulter, Inc. | Systems and methods for detecting the presence of a biological status using clustering |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4692327A (en) * | 1984-09-06 | 1987-09-08 | Fujimori Kogyo Co., Inc. | Laminated film for packaging |
| US5500410A (en) * | 1989-03-29 | 1996-03-19 | Gruppo Lepetit S.P.A. | Substituted alkylamide derivatives of teicoplanin |
| US5840684A (en) * | 1994-01-28 | 1998-11-24 | Eli Lilly And Company | Glycopeptide antibiotic derivatives |
| US5488131A (en) * | 1994-03-23 | 1996-01-30 | California Institute Of Technology | Synthesis of compounds with predetermined chirality |
| US5919756A (en) * | 1996-06-28 | 1999-07-06 | Eli Lilly And Company | Amides |
| BRPI9914221B8 (pt) * | 1998-12-23 | 2021-05-25 | Advanced Medicine Inc | derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos |
| US6699836B2 (en) * | 1999-04-02 | 2004-03-02 | The Trustees Of Princeton University | Vancomycin analogs |
| US6498238B1 (en) * | 1999-05-19 | 2002-12-24 | Princeton University | Glycopeptide antibacterial compounds, compositions containing same and methods of using same |
| US20030008812A1 (en) * | 2001-02-02 | 2003-01-09 | Christensen Burton G. | Glycopeptide derivatives |
| US7348309B2 (en) * | 2001-03-30 | 2008-03-25 | Wisconsin Alumni Research Foundation | Glycorandomization and production of novel vancomycin analogs |
| KR20060091049A (ko) | 2002-08-30 | 2006-08-17 | 케이.유.루벤 리서치 앤드 디벨럽먼트 | 글리코펩티드 항생제 및 그것의 반합성 유도체 및 항바이러스제로서의 그것의 사용 |
| AU2003287605A1 (en) * | 2002-11-12 | 2004-06-03 | Enzon Pharmaceuticals, Inc. | Polymeric prodrugs of vancomycin |
| US7521418B2 (en) * | 2003-05-27 | 2009-04-21 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| US7368422B2 (en) * | 2005-02-28 | 2008-05-06 | Novartis Vaccines And Diagnostics Inc. | Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| US7632918B2 (en) * | 2005-02-28 | 2009-12-15 | Novartis Vaccines And Diagnostics, Inc. | Semi-synthetic glycopeptides with antibiotic activity |
-
2006
- 2006-02-24 US US11/361,311 patent/US7368422B2/en not_active Expired - Fee Related
- 2006-02-27 BR BRPI0607701-3A patent/BRPI0607701A2/pt not_active IP Right Cessation
- 2006-02-27 JP JP2007558123A patent/JP2008531701A/ja active Pending
- 2006-02-27 WO PCT/US2006/007021 patent/WO2006093933A2/en not_active Ceased
- 2006-02-27 EP EP06736361A patent/EP1858908A4/en not_active Withdrawn
- 2006-02-27 CA CA002599336A patent/CA2599336A1/en not_active Abandoned
- 2006-02-27 AU AU2006218743A patent/AU2006218743A1/en not_active Abandoned
-
2008
- 2008-03-05 US US12/043,076 patent/US20080214444A1/en not_active Abandoned
-
2009
- 2009-02-18 JP JP2009035654A patent/JP2009102445A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007138110A3 (en) | Compounds that interact with ion channels, in particular with ion channels from the kv family | |
| JP2009504764A5 (enExample) | ||
| JP2008510770A5 (enExample) | ||
| JP2011526924A5 (enExample) | ||
| JP2007522220A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| EP2682387A3 (en) | C7-fluoro substituted tetracycline compounds | |
| JP2009502743A5 (enExample) | ||
| EP2457918A3 (en) | Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes | |
| PT2322525E (pt) | Derivados de purina para utilização como agonistas do recetor de adenosina a2a | |
| JP2006514012A5 (enExample) | ||
| JP2010515731A5 (enExample) | ||
| WO2010026436A3 (en) | 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders | |
| WO2009013348A3 (en) | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions | |
| JP2009511508A5 (enExample) | ||
| JP2013514980A5 (enExample) | ||
| JP2011507896A5 (enExample) | ||
| JP2008531701A5 (enExample) | ||
| JP2009520695A5 (enExample) | ||
| EP2145877A3 (en) | Aurora Kinase inhibitors | |
| JP2007500222A5 (enExample) | ||
| JP2008531702A5 (enExample) | ||
| WO2007138112A3 (en) | Compounds that interact with ion channels, in particular with ion channels from the kv family | |
| JP2010514734A5 (enExample) | ||
| JP6293736B2 (ja) | 細菌感染症を治療するための方法および組成物 |